Prognostic factors in Japanese men with high-Gleason metastatic castration-resistant prostate cancer

BACKGROUND: Several therapeutic agents are available for metastatic castration-resistant prostate cancer (CRPC). However, prognosis is still not well developed. The Gleason score (GS) is a prognostic factor available for patients with metastatic CRPC. GSs ranging from 6 to 10 and GSs ≥8 are usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimoto, Mitsuhisa, Fujita, Kazutoshi, Yamamoto, Yutaka, Hashimoto, Mamoru, Adomi, Shogo, Banno, Eri, Saito, Yoshitaka, Shimizu, Nobutaka, Mori, Yasunori, Minami, Takafumi, Nozawa, Masahiro, Nose, Kazuhiro, Hirayama, Akihide, Yoshimura, Kazuhiro, Uemura, Hirotsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459578/
https://www.ncbi.nlm.nih.gov/pubmed/36093511
http://dx.doi.org/10.21037/tcr-22-375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459578/
https://www.ncbi.nlm.nih.gov/pubmed/36093511
http://dx.doi.org/10.21037/tcr-22-375

Ejemplares similares